Revenue for Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's current revenue (TTM) is $45.13B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$45.13B
YoY change
+5.7%
5Y CAGR
+5.1%
Peak year (2025)
$44.33B
Cumulative revenue
$871.83B
Revenue history chart for Abbott Laboratories (ABT) from 1985 to 2025
Revenue history table for Abbott Laboratories (ABT) from 1985 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $44.33B | +5.7% | ||
| 2024 | $41.95B | +4.6% | ||
| 2023 | $40.11B | -8.1% | ||
| 2022 | $43.65B | +1.3% | ||
| 2021 | $43.08B | +24.5% | ||
| 2020 | $34.61B | +8.5% | ||
| 2019 | $31.90B | +4.3% | ||
| 2018 | $30.58B | +11.6% | ||
| 2017 | $27.39B | +31.3% | ||
| 2016 | $20.85B | +2.2% | ||
| 2015 | $20.41B | +0.8% | ||
| 2014 | $20.25B | -7.3% | ||
| 2013 | $21.85B | -45.2% | ||
| 2012 | $39.87B | +2.6% | ||
| 2011 | $38.85B | +10.5% | ||
| 2010 | $35.17B | +14.3% | ||
| 2009 | $30.77B | +4.2% | ||
| 2008 | $29.53B | +13.9% | ||
| 2007 | $25.91B | +15.3% | ||
| 2006 | $22.48B | +0.6% | ||
| 2005 | $22.34B | +13.5% | ||
| 2004 | $19.68B | -0.0% | ||
| 2003 | $19.68B | +11.3% | ||
| 2002 | $17.68B | +8.6% | ||
| 2001 | $16.29B | +18.5% | ||
| 2000 | $13.75B | +4.3% | ||
| 1999 | $13.18B | +5.6% | ||
| 1998 | $12.48B | +5.0% | ||
| 1997 | $11.88B | +7.9% | ||
| 1996 | $11.01B | +10.0% | ||
| 1995 | $10.01B | +9.4% | ||
| 1994 | $9.16B | +8.9% | ||
| 1993 | $8.41B | +7.1% | ||
| 1992 | $7.85B | +14.2% | ||
| 1991 | $6.88B | +11.7% | ||
| 1990 | $6.16B | +14.5% | ||
| 1989 | $5.38B | +9.0% | ||
| 1988 | $4.94B | +12.5% | ||
| 1987 | $4.39B | +15.2% | ||
| 1986 | $3.81B | +13.3% | ||
| 1985 | $3.36B | — |
Revenue values are taken from Abbott Laboratories's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Abbott Laboratories (ABT) most recent annual revenue stands at $44.33B (2025) – grew 5.7% year-over-year.
Across 2020–2025 (5 years), Abbott Laboratories revenue produced a CAGR of +5.1% – sustaining 2 straight years of year-over-year growth.
Across the available history, revenue reached its high of $44.33B in 2025 and its low of $3.36B in 1985.
Within Healthcare, Abbott Laboratories (ABT) ranks 8th among 8 peers we track. The peer median for revenue is $65.09B.
Abbott Laboratories Revenue by Year
Abbott Laboratories Revenue 2025: $44.33B
Abbott Laboratories revenue in 2025 was $44.33B, grew 5.7% from 2024. This figure represents the highest annual value in the available history.
Abbott Laboratories Revenue 2024: $41.95B
Abbott Laboratories revenue in 2024 was $41.95B, edged up 4.6% from 2023.
Abbott Laboratories Revenue 2023: $40.11B
Abbott Laboratories revenue in 2023 was $40.11B, declined 8.1% below 2022.
Abbott Laboratories Revenue 2022: $43.65B
Abbott Laboratories revenue in 2022 was $43.65B, edged up 1.3% from 2021.
Abbott Laboratories Revenue 2021: $43.08B
Abbott Laboratories revenue in 2021 was $43.08B.
See more financial history for Abbott Laboratories (ABT).
Sector peers — Revenue
Companies in the same sector as Abbott Laboratories, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is Abbott Laboratories's revenue?
- Latest reported revenue for Abbott Laboratories (ABT) is $45.13B (period ending March 31, 2026).
How has Abbott Laboratories revenue changed year-over-year?
- Abbott Laboratories (ABT) revenue changed +5.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Abbott Laboratories revenue?
- Abbott Laboratories (ABT) revenue compound annual growth rate is +5.1% over the most recent 5 years available.
When did Abbott Laboratories revenue hit its highest annual value?
- Abbott Laboratories revenue reached its highest annual value of $44.33B in 2025.
What was Abbott Laboratories revenue in 2024?
- Abbott Laboratories (ABT) revenue in 2024 was $41.95B.
What was Abbott Laboratories revenue in 2025?
- Abbott Laboratories (ABT) revenue in 2025 was $44.33B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ABT Overview
Company profile, financial tools, and key metrics
ABT Revenue Counter
Earns $1,431 every second. See per minute, hour, and day.
ABT Earnings Counter
Earns $199.01 per second net profit. See per minute, hour, and day.
ABT Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
ABT What If Invested
What if you had invested $1,000? See historical returns from any date.
ABT How It Makes Money
Discover visual breakdown of $45.13B in revenue — where it comes from and where it goes.
ABT Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABT Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABT Daily Price Character
Steady · 48.2% historical win rate (green days). Streaks & record days.
ABT Buybacks
0.41% TTM buyback yield. Shareholder yield & SBC comparison.
ABT Stock Split History
9 splits on record. Dates, ratios, and cumulative multiple.
ABT Dividend Profile
Yield: 2.67%. Safety: 6/8. See full history.
ABT Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABT Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.